Validation of a Concussion Screening Battery for Use in Medical Settings: Predicting Centers for Disease Control Concussion Symptoms in Children and Adolescents.


Journal

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
ISSN: 1873-5843
Titre abrégé: Arch Clin Neuropsychol
Pays: United States
ID NLM: 9004255

Informations de publication

Date de publication:
20 Apr 2020
Historique:
received: 03 04 2019
revised: 15 05 2019
accepted: 18 07 2019
pubmed: 26 9 2019
medline: 15 9 2020
entrez: 26 9 2019
Statut: ppublish

Résumé

Effective screening for concussion is increasingly important, and medical professionals play a critical role in diagnostic and return-to-play decisions. However, few well-validated measures are available to assist in those decisions. This study aims to determine whether previously validated measures assessing neurocognitive and neurobehavioral abilities can predict Centers for Disease Control (CDC) concussion symptom endorsement in a sample of child or youth athletes. Participants were 113 individuals, aged 6-17, representing 29 consecutive cases undergoing a post-concussion evaluation by a pediatric neurologist and 84 consecutive cases completing standardized baseline assessments (i.e., not being evaluated as a follow-up to a concussion). All participants completed the same standardized battery of tests comprised of the Connors' Continuous Performance Test (CPT 3), the Balance Error Scoring System (BESS), and the NIH 4-Meter Gait Test as well as completing a checklist of CDC concussion symptoms. Regression analyses indicate that the screening battery explained 33% of the variance (d = 1.4) in concussion symptom endorsement, after controlling for age. The neurocognitive test alone (CPT 3) accounts for 21.5% of the variance (d = 1.05) in symptoms after controlling for age, and the neurobehavioral measures (BESS and NIH 4-Meter Gait) then account for an additional 11.5% variance (accounting for 18.6% variance, d = .96, when entered first). These effect sizes are considered large to very large and reflect a marked increase in predictive validity relative to existing measures commonly used in concussion assessments. A relatively brief screening battery can function in medical settings to predict significant and substantial variability in CDC concussion symptoms in a pediatric sample.

Identifiants

pubmed: 31553427
pii: 5565030
doi: 10.1093/arclin/acz041
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-274

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Auteurs

Len Lecci (L)

Department of Psychology, University of North Carolina Wilmington, Wilmington, NC 28403, USA.

Mark Williams (M)

Internal Medicine, New Hanover Regional Medical Center, Wilmington, NC 28403, USA.

Sasidharan Taravath (S)

Pediatric Neurology, New Hanover Regional Medical Center, Wilmington, NC 28403, USA.

Harrison G Frank (HG)

Frank Institute for Health and Wellness, Wilmington, NC 28403, USA.

Kelly Dugan (K)

Department of Psychology, University of North Carolina Wilmington, Wilmington, NC 28403, USA.

Ryan Page (R)

Department of Psychology, University of North Carolina Wilmington, Wilmington, NC 28403, USA.

Julian Keith (J)

Department of Psychology, University of North Carolina Wilmington, Wilmington, NC 28403, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH